©2025 Stanford Medicine
Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms
Not Recruiting
Trial ID: NCT04819074
Purpose
Accurate preoperative identification of patients at high risk for adverse outcomes would be clinically advantageous, as it would allow enhanced resource preparation, better surgical decision-making, enhanced patient education and informed consent, and potentially even modification of certain modifiable risk factors. The aim of the Prediction of adverse events after microsurgery for intracranial unruptured aneurysms (PRAEMIUM) study is therefore to develop and externally validate a clinically applicable, robust ML-based prediction tool based on multicenter data from a range of international centers.
Official Title
The Prediction of Adverse Events After Microsurgery for Intracranial Unruptured Aneurysms (PRAEMIUM) Study
Stanford Investigator(s)
Gary K. Steinberg, MD, PhD
Bernard and Ronni Lacroute-William Randolph Hearst Professor of Neurosurgery and Neurosciences and Professor, by courtesy, of Neurology and Neurological Sciences
Eligibility
Inclusion Criteria:
* Adult patients (18 or older)
* Undergone microsurgical treatment for unruptured intracranial aneurysm
* Patients with prior SAH may only be included when surgical treatment occurred at least 4 weeks after ictus.
* Treated from January 1st 2010 onwards
Exclusion Criteria:
* No specific exclusion criteria
Intervention(s):
procedure: Microsurgery
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Gary K Steinberg